Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study

BACKGROUND: It is estimated that around 15–30% of patients with early stage colon cancer benefit from adjuvant chemotherapy. We are currently not capable of upfront selection of patients who benefit from chemotherapy, which indicates the need for additional predictive markers for response to chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, I., van de Weerd, S., Roodhart, J. M. L., Vink, G. R., van den Braak, R. R. J. Coebergh, Jimenez, C. R., Elias, S. G., van Vliet, D., Koelink, M., Hong, E., van Grevenstein, W. M. U., van Oijen, M. G. H., Beets-Tan, R. G. H., van Krieken, J. H. J. M., IJzermans, J. N. M., Medema, J. P., Koopman, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433093/
https://www.ncbi.nlm.nih.gov/pubmed/32811457
http://dx.doi.org/10.1186/s12885-020-07236-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433093/
https://www.ncbi.nlm.nih.gov/pubmed/32811457
http://dx.doi.org/10.1186/s12885-020-07236-y

Ejemplares similares